Effects of low blood pressure in cognitively impaired elderly patients treated with antihypertensive drugs
- PMID: 25730775
- DOI: 10.1001/jamainternmed.2014.8164
Effects of low blood pressure in cognitively impaired elderly patients treated with antihypertensive drugs
Abstract
Importance: The prognostic role of high blood pressure and the aggressiveness of blood pressure lowering in dementia are not well characterized.
Objective: To assess whether office blood pressure, ambulatory blood pressure monitoring, or the use of antihypertensive drugs (AHDs) predict the progression of cognitive decline in patients with overt dementia and mild cognitive impairment (MCI).
Design, setting, and participants: Cohort study between June 1, 2009, and December 31, 2012, with a median 9-month follow-up of patients with dementia and MCI in 2 outpatient memory clinics.
Main outcomes and measures: Cognitive decline, defined as a Mini-Mental State Examination (MMSE) score change between baseline and follow-up.
Results: We analyzed 172 patients, with a mean (SD) age of 79 (5) years and a mean (SD) MMSE score of 22.1 (4.4). Among them, 68.0% had dementia, 32.0% had MCI, and 69.8% were being treated with AHDs. Patients in the lowest tertile of daytime systolic blood pressure (SBP) (≤ 128 mm Hg) showed a greater MMSE score change (mean [SD], -2.8 [3.8]) compared with patients in the intermediate tertile (129-144 mm Hg) (mean [SD], -0.7 [2.5]; P = .002) and patients in the highest tertile (≥ 145 mm Hg) (mean [SD], -0.7 [3.7]; P = .003). The association was significant in the dementia and MCI subgroups only among patients treated with AHDs. In a multivariable model that included age, baseline MMSE score, and vascular comorbidity score, the interaction term between low daytime SBP tertile and AHD treatment was independently associated with a greater cognitive decline in both subgroups. The association between office SBP and MMSE score change was weaker. Other ambulatory blood pressure monitoring variables were not associated with MMSE score change.
Conclusions and relevance: Low daytime SBP was independently associated with a greater progression of cognitive decline in older patients with dementia and MCI among those treated with AHDs. Excessive SBP lowering may be harmful for older patients with cognitive impairment. Ambulatory blood pressure monitoring can be useful to help avoid high blood pressure overtreatment in this population.
Comment in
-
Blood pressure control and cognitive impairment--why low is not always better.JAMA Intern Med. 2015 Apr;175(4):586-7. doi: 10.1001/jamainternmed.2014.8202. JAMA Intern Med. 2015. PMID: 25730401 No abstract available.
-
Goal blood pressure for cognition-impaired patients: let's treat the patients--not the numbers.J Am Soc Hypertens. 2015 Jul;9(7):504-6. doi: 10.1016/j.jash.2015.04.005. Epub 2015 May 1. J Am Soc Hypertens. 2015. PMID: 26072256 No abstract available.
-
Managing high blood pressure in older persons with decline in function.Am J Kidney Dis. 2015 Nov;66(5):745-7. doi: 10.1053/j.ajkd.2015.06.011. Epub 2015 Jul 15. Am J Kidney Dis. 2015. PMID: 26188432 No abstract available.
-
[Do not lower blood pressure too low in dementia].MMW Fortschr Med. 2015 Nov 19;157(20):41. doi: 10.1007/s15006-015-7557-2. MMW Fortschr Med. 2015. PMID: 26977513 German. No abstract available.
Similar articles
-
Independent association of cognitive dysfunction with cardiac hypertrophy irrespective of 24-h or sleep blood pressure in older hypertensives.Am J Hypertens. 2012 Jun;25(6):657-63. doi: 10.1038/ajh.2012.27. Epub 2012 Mar 15. Am J Hypertens. 2012. PMID: 22421907
-
Hypertension, Dietary Sodium, and Cognitive Decline: Results From the Women's Health Initiative Memory Study.Am J Hypertens. 2016 Feb;29(2):202-16. doi: 10.1093/ajh/hpv081. Epub 2015 Jul 1. Am J Hypertens. 2016. PMID: 26137952 Free PMC article.
-
Systolic Blood Pressure and Cognitive Decline in Older Adults With Hypertension.Ann Fam Med. 2019 Mar;17(2):100-107. doi: 10.1370/afm.2367. Ann Fam Med. 2019. PMID: 30858252 Free PMC article.
-
[Hypertension in the elderly: particularities and precautions].Presse Med. 2009 Apr;38(4):614-20. doi: 10.1016/j.lpm.2008.11.016. Epub 2009 Mar 4. Presse Med. 2009. PMID: 19264441 Review. French.
-
Treating Hypertension to Prevent Cognitive Decline and Dementia: Re-Opening the Debate.Adv Exp Med Biol. 2017;956:447-473. doi: 10.1007/5584_2016_98. Adv Exp Med Biol. 2017. PMID: 27757933 Review.
Cited by
-
Population-level trends in self-reported healthcare utilization among older adults in Mexico with and without cognitive impairment.BMC Geriatr. 2024 Aug 2;24(1):652. doi: 10.1186/s12877-024-05247-z. BMC Geriatr. 2024. PMID: 39095702 Free PMC article.
-
Effects of the discontinuation of antihypertensive treatment on neuropsychiatric symptoms and quality of life in nursing home residents with dementia (DANTON): a multicentre, open-label, blinded-outcome, randomised controlled trial.Age Ageing. 2024 Jul 2;53(7):afae133. doi: 10.1093/ageing/afae133. Age Ageing. 2024. PMID: 38970547 Free PMC article. Clinical Trial.
-
Alzheimer's Disease: Treatment Today and Tomorrow.Ann Indian Acad Neurol. 2023 Jul-Aug;26(4):326-333. doi: 10.4103/aian.aian_254_23. Epub 2023 Aug 28. Ann Indian Acad Neurol. 2023. PMID: 37970257 Free PMC article.
-
Prevalence and correlates of frailty in older hypertensive outpatients according to different tools: the HYPER-FRAIL pilot study.J Hypertens. 2024 Jan 1;42(1):86-94. doi: 10.1097/HJH.0000000000003559. Epub 2023 Oct 3. J Hypertens. 2024. PMID: 37698894 Free PMC article.
-
Preferences for deprescribing antihypertensive medications amongst clinicians, carers and people living with dementia: a discrete choice experiment.Age Ageing. 2023 Aug 1;52(8):afad153. doi: 10.1093/ageing/afad153. Age Ageing. 2023. PMID: 37596920 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
